No products in the cart.

Description
PRODUCT DESCRIPTION:
Hydroxyprogesterone is a long-acting synthetic progestin used to reduce the risk of preterm birth in women with a history of spontaneous preterm deliveries.
It also plays a role in selected gynecological and endocrine disorders, including amenorrhea and abnormal uterine bleeding.
The 250 MG/ML intramuscular formulation provides sustained progestational effect, ensuring consistent hormonal support over a prolonged period.
Manufactured in GMP-compliant facilities, the product offers both efficacy and safety for use in obstetric and gynecological settings.
Formulation & Presentation:
- Dosage Form: Injectable Solution
- Presentation: Sterile, single-use ampoule or vial (customizable as per market demand)
- Available Strengths: 250 MG/ML
- Route of Administration: Intramuscular Only (IM) or as per clinical indication and severity (As per physician’s discretion or decision)
Therapeutic Indications:
- Prevention of recurrent preterm birth in women with prior spontaneous preterm delivery
- Treatment of secondary amenorrhea
- Management of dysfunctional uterine bleeding due to hormonal imbalance
- Adjunct in hormone replacement therapy protocols (as clinically indicated)
Side Effects:
- COMMON:
- Pain or swelling at injection site
- Headache or dizziness
- Breast tenderness
- Mild nausea
- SERIOUS (RARE):
- Allergic reactions
- Thromboembolic events
- Jaundice or hepatic dysfunction
- Depression or mood alterations
- PRECAUTIONS:
- Contraindicated in known or suspected cases of breast, liver, or hormone-sensitive cancers
- Use with caution in patients with a history of thromboembolic disorders
- Periodic liver function monitoring is advised during prolonged therapy
- Should be administered under strict medical supervision, especially in obstetric settings
Be the first to review “Hydroxyprogesterone Injection 250 MG/ML”
TECHNICAL INFORMATION
Product Specifications:
- HSN Code: To be assigned per international classification standards & import jurisdiction
- Weight: Approx. 40g per Carton (With Packaging)
- Dimensions: (15x1x8 CMS)
- Shelf Life (Subject To Country Specific Guidelines): 2 to 3 years under recommended storage conditions from date of manufacture or as per label specifications
- Storage: Oil-based injectable solution requiring cold-chain logistics (if specified by packaging). Protect from moisture and direct sunlight. The solution should be used strictly as per label guidelines.
Regulatory Status & Supply Information:
- Regulatory Status: WHO-GMP Complaint Manufacturing. Further certifications available on request
- Exports Ready Dossiers: Dossier Available (CTD/eCTD formats)
- Stability: Compliant
- MOQ: Negotiable. Based on market & registration status
- Export Options: Available for private label, institutional supply, or branded export
Who Should Source This Product?
- Hydroxyprogesterone Injection 250 MG/ML is suitable for obstetric and gynecological hospitals, maternal health programs, fertility centers, government healthcare procurement agencies, and NGOs working in women’s health.
- It is especially relevant in regions across Africa, Latin America, Southeast Asia, and Middle East where reducing preterm birth is a public health priority.
Why Source from PHARMET?
- Single-window sourcing for diverse pharma needs
- Export-ready documentation & regulatory support
- Adaptable documentation support for effective registration
- Trusted consortium network, simplifying India’s complex pharma supply chain
- Multiple approved manufacturers for best fit in import country
- Network of audited, compliant manufacturers across India
- Customizable & flexible branding, packaging & formulation options
- End-to-end logistics flexibility & support
- Deep expertise in exporting specialty injectables & all products
CONTACT DETAILS:
- E-MAIL: hello@pharmet.io
- Phone/WhatsApp Number: +91 9999091881
- Website: www.pharmet.io
Reviews
There are no reviews yet.